BCA
TMO icon

Bernzott Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bernzott Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,430
Closed -$2.23M – 51
2021
Q2 		$2.23M Sell
4,430
-684
-13% -$323K 0.19% 45
2021
Q1 		$2.33M Sell
5,114
-596
-10% -$284K 0.2% 42
2020
Q4 		$2.66M Sell
5,710
-275
-5% -$129K 0.24% 40
2020
Q3 		$2.64M Sell
5,985
-15,036
-72% -$6.21M 0.25% 37
2020
Q2 		$7.62M Sell
21,021
-5,750
-21% -$1.93M 0.96% 32
2020
Q1 		$7.59M Sell
26,771
-3,535
-12% -$1.11M 1.17% 31
2019
Q4 		$9.85M Buy
30,306
+1,107
+4% +$336K 1.03% 32
2019
Q3 		$8.51M Sell
29,199
-520
-2% -$149K 1.02% 34
2019
Q2 		$8.73M Sell
29,719
-662
-2% -$182K 1.05% 34
2019
Q1 		$8.32M Sell
30,381
-560
-2% -$139K 1.01% 35
2018
Q4 		$6.92M Sell
30,941
-265
-0.8% -$62.2K 0.97% 37
2018
Q3 		$7.62M Sell
31,206
-485
-2% -$112K 0.88% 36
2018
Q2 		$6.56M Sell
31,691
-620
-2% -$132K 0.82% 37
2018
Q1 		$6.67M Sell
32,311
-530
-2% -$111K 0.87% 32
2017
Q4 		$6.24M Buy
32,841
+4,503
+16% +$863K 0.83% 32
2017
Q3 		$5.36M Sell
28,338
-280
-1% -$50.7K 0.76% 31
2017
Q2 		$4.99M Sell
28,618
-200
-0.7% -$33.6K 0.82% 30
2017
Q1 		$4.43M Sell
28,818
-578
-2% -$88.3K 0.76% 34
2016
Q4 		$4.15M Buy
29,396
+90
+0.3% +$13.3K 0.71% 35
2016
Q3 		$4.66M Sell
29,306
-400
-1% -$61.6K 0.86% 34
2016
Q2 		$4.39M Sell
29,706
-379
-1% -$55.9K 0.86% 37
2016
Q1 		$4.26M Sell
30,085
-3,020
-9% -$405K 0.81% 35
2015
Q4 		$4.7M Sell
33,105
-60
-0.2% -$8K 0.91% 35
2015
Q3 		$4.05M Sell
33,165
-400
-1% -$52.1K 0.93% 35
2015
Q2 		$4.36M Sell
33,565
-200
-0.6% -$26.1K 0.93% 33
2015
Q1 		$4.54M Sell
33,765
-7,990
-19% -$1.03M 1.01% 32
2014
Q4 		$5.23M Buy
41,755
+29,600
+244% +$3.6M 1.14% 35
2014
Q3 		$1.48M Buy
12,155
+1,375
+13% +$167K 0.35% 38
2014
Q2 		$1.27M Buy
+10,780
New +$1.27M 0.29% 39

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bernzott Capital Advisors's TMO Position: Q3 2021 in Review

Bernzott Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2021, closing a stake of 4,430 shares — an estimated $2.23M sold.

Bernzott Capital Advisors first reported a position in TMO in Q2 2014 and held it in 29 quarters. The position peaked at $9.85M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Bernzott Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2021 after selling out during the quarter.
  • Bernzott Capital Advisors sold 4,430 Thermo Fisher Scientific shares in Q3 2021, an estimated $2.23M.
  • Bernzott Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2014 and held it in 29 quarters.
  • Bernzott Capital Advisors's Thermo Fisher Scientific position peaked at $9.85M in Q4 2019.
  • 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Bernzott Capital Advisors's 13F filing for Q3 2021, filed 19 Oct 2021.